CDK2 and neoplasm: Because the effects of miR-3140 on in vitro tumor cell growth were much greater than those of si-CDK2 and si-EGFR (Figs 1e and 2d–f), concurrent downregulation of additional target genes may be necessary for the induction of miR-3140-mediated inhibition of tumor cell growth.